SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-190026
Filing Date
2014-05-08
Accepted
2014-05-08 16:19:01
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d722939d10q.htm 10-Q 614446
2 EX-31.1 d722939dex311.htm EX-31.1 6518
3 EX-31.2 d722939dex312.htm EX-31.2 6559
4 EX-32 d722939dex32.htm EX-32 4398
  Complete submission text file 0001193125-14-190026.txt   7612703

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT dndn-20140331.xml EX-101.INS 1510309
6 XBRL TAXONOMY EXTENSION SCHEMA dndn-20140331.xsd EX-101.SCH 48901
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dndn-20140331_cal.xml EX-101.CAL 46551
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dndn-20140331_def.xml EX-101.DEF 128473
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE dndn-20140331_lab.xml EX-101.LAB 342506
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dndn-20140331_pre.xml EX-101.PRE 290189
Mailing Address 1301 2ND AVE. SUITE 3200 SEATTLE WA 98101
Business Address 1301 2ND AVE. SUITE 3200 SEATTLE WA 98101 206-219-7815
DENDREON CORP (Filer) CIK: 0001107332 (see all company filings)

IRS No.: 223203193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35546 | Film No.: 14825201
SIC: 2834 Pharmaceutical Preparations